Effect of combination therapy with ciprofloxacin and azlocillin in intensive care patients with pneumonia and/or sepsis.
Engelhardt
D
D
Medical Department II, Klinikum Grosshandern, University of Munich, FRG.
Ruckdeschel
G
G
D000900:Anti-Bacterial Agents / Q000097:blood / Q000627:therapeutic use; D001390:Azlocillin / Q000097:blood / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification; D002939:Ciprofloxacin / Q000097:blood / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003422:Critical Care; D004359:Drug Therapy, Combination; D006801:Humans; D007362:Intensive Care Units; D008826:Microbial Sensitivity Tests; D018410:Pneumonia, Bacterial / Q000188:drug therapy*; D018805:Sepsis / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D001390:Azlocillin